Boehringer Ingelheim BioXcellence. Producing Value. Global Contract Manufacturing Excellence
|
|
- Olivia O’Brien’
- 6 years ago
- Views:
Transcription
1 Boehringer Ingelheim BioXcellence Producing Value Global Contract Manufacturing Excellence
2 Your World Class Contract Manufacturer Boehringer Ingelheim BioXcellence
3 Producing Value Boehringer Ingelheim BioXcellence is a leading contract manufacturer with more than 35 years of experience and 19 biopharmaceutical products brought to market. We provide tailor-made solutions where you need us, when you need us Our transparent, modular approach -regardless of your project s stage, scope or scales- makes outsourcing easy Our experience, reliability and flexibility help you to better focus on your strategic priorities As a family-owned business, we pride ourselves on stability and committed long-term relationships 3
4 Boehringer Ingelheim BioXcellence Our Mission: Producing Value 4 BioXcellence Producing Value
5 Producing Value We provide smart manufacturing solutions to the industry, empowering our customers to successfully navigate the challenges of the biopharmaceutical market. Boehringer Ingelheim has a long history in the field of biotechnology, having been in the industry for more than 35 years and in contract manufacturing since During that time we have helped our customers to bring 19 molecules to the market. This has earned us a reputation as one of the most experienced and reliable contract manufacturing organizations (CMO) in the world. Boehringer Ingelheim Contract Manufacturing has now evolved into Boehringer Ingelheim BioXcellence - your dedicated contract manufacturer. Boehringer Ingelheim BioXcellence provides the entire production technology chain from DNA to fill and finish at our facilities in Biberach (Germany), Vienna (Austria) and Fremont (USA). We have a total commercial capacity of more than 200,000 liters with flexible scales between 400 and 12,000 liters. For products derived from microbial fermentation technology more than 12,000 liters of commercial capacity with flexible scales from 200 liters to 4,500 liters are installed at our site in Vienna, Austria. With more than 2,300 employees in biopharma development, quality and manufacturing Boehringer Ingelheim BioXcellence is your sustainable, committed contract development and manufacturing partner - producing value for you. 5
6 Boehringer Ingelheim BioXcellence Where you need us, when you need us All of the elements required for outsourcing biopharmaceutical development and manufacture, from high expression systems to fill and finish, including patient convenient application systems, can be found within the service offering of Boehringer Ingelheim BioXcellence. We offer our customers an integrated, seamless approach to reliable and efficient outsourcing. This includes process development, cell culture technologies, microbial technologies, upstream technologies, downstream technologies, tech transfer and scale up, process validation, pharmaceutical development, analytical labs, CMC documentation support, formulation, fill and finish, packaging, shipping validation and much more. Whether you are looking for contract development and manufacturing of individual work packages only or for a partner for the entire product life cycle we are looking forward to talking to you. Where you need us when you need us. 6 BioXcellence Producing Value
7 Producing Value Our Biopharmaceuticals Production Sites Fremont, California, USA Biberach, Germany Vienna, Austria Experience Boehringer Ingelheim Quality At Boehringer Ingelheim BioXcellence we are well aware of the responsibility that comes with contract manufacturing producing reliable biopharmaceutical products for patients. To this end, our production plants operate under cgmp and are approved as such. We not only meet the highest level of compliance, but strive to exceed it, both through regular internal audits and by asking external consultants to give us an outside perspective. Last and most important, we value the input of our partners through their regular audits and leverage these opportunities to continually improve our processes. The track record of our multi-product facilities include inspections by the Food and Drug Administration (FDA), the European Medicines European Medicines Agency (EMA), Health Canada, MHLW, SFDA, and many other authorities. Product Company Year Type Berofor Boehringer Ingelheim 1983 Microbial Actilyse Boehringer Ingelheim 1987 Mammalian Imukin Boehringer Ingelheim 1990 Microbial Betaferon Bayer 1995 Microbial Verluma Boehringer Ingelheim 1996 Mammalian Enbrel (US) Pfizer/Amgen 1998 Mammalian Synagis (US) Medimmune/Abbott 1998 Mammalian Synagis (EU) Medimmune/Abbott 1999 Mammalian Beromun Boehringer Ingelheim 1999 Microbial Enbrel (EU) Pfizer/Amgen 2000 Mammalian Metalyse Boehringer Ingelheim 2001 Mammalian Campath (US) Genzyme 2001 Mammalian Actimmune (US) Intermune 2001 Microbial Synagis (JP) Medimmune/Abbott 2002 Mammalian Bexxar (US) GSK/Corixa 2003 Mammalian Erbitux (EU) Merck Serono 2004 Mammalian Enbrel (JP) Pfizer/Amgen 2004 Mammalian Preotact Nycomed 2007 Microbial Erbitux (JP) Merck Serono 2008 Mammalian Infergen 3 Rivers 2009 Microbial Forteo Eli Lilly 2010 Microbial Prolia (US/EU) Amgen/GSK 2010 Mammalian Revasc /Iprivasc Canyon 2010 Microbial Vectibix (US) Amgen 2011 Mammalian Betaseron (US) Bayer 2011 Microbial 7
8 Get your Product to Market faster Boehringer Ingelheim BioXcellence 8 BioXcellence Producing Value
9 Producing Value Finding the optimal strategy together It is our ambition to maintain our position as one of the industry s most trusted manufacturing partners. As your partner, we offer you the opportunity to leverage our expertise and process excellence at any stage of the development and production process. Our transparent and modular approach guarantees you complete project flexibility while maintaining full control over the process. Together with you, we will be happy to identify the project design that is most suitable for your strategic objectives and then implement it while ensuring maximum efficiency, safety, quality and cost effectiveness. Lean-to-Clinic Reaching investigational new drug application (IND) is a critical milestone for most companies. Boehringer Ingelheim BioXcellence has established a Lean-to-Clinic program for monoclonal antibodies which consists of streamlined work packages based on platform technologies and standardized processes. It significantly speeds up cell line development, Phase I process development and preclinical and clinical supplies. Smart-to-Launch Our Smart-to-Launch approach ensures fast track project transfer to commercial scale. We transfer your project into our facilities and deliver clinical phase III material, commercial product or early second source supply focused on extremely short timelines. Tailored Transfer We provide established and proven transfer procedures to enable seamless, reliable second source- and legacy product supply. Our well experienced transfer teams develop together with you a tailored transfer scenario. In a one team approach all necessary work packages for facility adaptation, production transfer and installation of product specific analytical quality methods are identified and executed focused on product- and process comparability. Pharmaceutical Development Boehringer Ingelheim BioXcellence offers pharmaceutical development of biopharmaceuticals, applying state-ofthe-art technologies for sophisticated pre-formulation, formulation and pharmaceutical process development. The dosage form portfolio ranges from solutions, highly concentrated liquid formulations, suspensions, lyophilized or spray-dried powders to inhalable presentations combined with state-of-the-art proprietary application systems. Fill and Finish We provide the entire drug product manufacturing chain comprising filling, lyophilization, visual inspection, labeling and packaging. Within our global manufacturing network we can supply different dosage forms such as liquid or lyophilized preparations in vials and technically more complex dosage forms such as prefilled syringes and dual-chamber cartridges. 9
10 Your Product. Our Passion. Local Business Development and Key Account Management globally Boehringer Ingelheim BioXcellence has established Business Development and Key Account Management (BD & KAM) teams in the major markets (Americas, Europe and Asia-Pacific). Our local expert representatives are the first point of contact for our customers. They take care of our customers and their projects from early information exchange to the end of the project, and ensure smooth transfer to our project management at our facilities in Austria, Germany or USA. 10 BioXcellence Producing Value
11 Producing Value Boehringer Ingelheim BioXcellence welcomes your enquiries, questions and feedback. Contact Americas Dr. Axel Schleyer Vice President BD & KAM Americas Contact Europe Dr. Monika Henninger-Erber Vice President BD & KAM Europe Contact Asia/Pacific Hans-Peter Grau Vice President BD & KAM Asia/Pacific Copyright Boehringer Ingelheim Pharma GmbH & Co. KG, September All rights reserved. No part of this brochure may be reproduced or transmitted in any form or by any means, electronic or photocopy, without permission in writing from Boehringer Ingelheim Pharma GmbH & Co. KG. September 2012
12
Boehringer Ingelheim BioXcellence. Producing Value. Global Contract Manufacturing Excellence
Boehringer Ingelheim BioXcellence Producing Value Global Contract Manufacturing Excellence Your World Class Contract Manufacturer Boehringer Ingelheim BioXcellence Producing Value Boehringer Ingelheim
More informationBoehringer Ingelheim Biopharmaceuticals in China. Your Reliable Contract Manufacturing Solution Provider
Boehringer Ingelheim Biopharmaceuticals in China Your Reliable Contract Manufacturing Solution Provider Dr. Bin Wang, Dr. Axel Schleyer Boehringer Ingelheim Biopharmaceuticals (China) Co., Ltd. Contact:
More informationPartner with the Global Leader in Drug Delivery Systems.
3M DRUG DELIVERY SYSTEMS Partner with the Global Leader in Drug Delivery Systems. Hurlingham, Argentina Manufacturing Facility Experts at Commercializing Innovation 3M is a global innovation company that
More informationPartner with the Global Leader in Drug Delivery Systems.
3M DRUG DELIVERY SYSTEMS Partner with the Global Leader in Drug Delivery Systems. Hurlingham, Argentina Manufacturing Facility Experts at Commercializing Innovation Drug Delivery Systems: It s in the detail
More informationPPD S EXPERT HEMATOLOGY AND ONCOLOGY TEAM
HEMATOLOGY ONCOLOGY PPD S EXPERT HEMATOLOGY AND ONCOLOGY TEAM COMMITTED TO ADVANCING DRUG DEVELOPMENT IN ONCOLOGY $ MARKETPLACE COMPLEXITIES increasingly competitive marketplace and rising cost pressures
More informationAN INTRODUCTION TO YPSODOSE FOR THE LARGE-VOLUME INJECTION OF BIOLOGICS
AN INTRODUCTION TO YPSODOSE FOR THE LARGE-VOLUME INJECTION OF BIOLOGICS In this article Ian Thompson, Vice-President Business Development at Ypsomed, describes self-injection device trends for larger injection
More informationSMARTPILOT FOR YPSOMATE: TRANSFORMING A PROVEN AUTOINJECTOR INTO A FULLY CONNECTED DEVICE
SMARTPILOT FOR YPSOMATE: TRANSFORMING A PROVEN AUTOINJECTOR INTO A FULLY CONNECTED DEVICE In this article, Orfeo Niedermann, Business Development Director, Ypsomed Delivery Systems, provides insights into
More informationConsumer Health Care V5.0_2013
Consumer Health Care Headquarters ProNovis GmbH Infanteriestr. 19/6 80797 Munich Germany Tel: +49 / 89 / 326676-30 Fax: +49 / 89 / 326676-35 www.pronovis.net info@pronovis.net Mission and Vision ProNovis
More informationnovo nordisk R&D AT A GLANCE
novo nordisk R&D AT A GLANCE LIU WEI & THOMAS JUNKER ALSTED Liu is a special technician and Thomas is an international postdoc in Research & Development in Novo Nordisk, Denmark PASSIONATE ABOUT PROTEINS
More informationBoehringer Ingelheim and investment in R&D. Volker Barkmann
Boehringer Ingelheim and investment in R&D Volker Barkmann I. Our Corporation Boehringer Ingelheim in brief Boehringer Ingelheim Center Our headquarters in Ingelheim, Germany Family-owned global corporation
More informationTHE COMPLEX JOURNEY OF A VACCINE PART I The manufacturing chain, regulatory requirements and vaccine availability
THE COMPLEX JOURNEY OF A VACCINE PART I The manufacturing chain, regulatory requirements and vaccine availability International Federation of Pharmaceutical Manufacturers & Associations THE COMPLEX JOURNEY
More informationPurolite Life Sciences Brand Positioning Catalyst
Purolite Life Sciences Brand Positioning Catalyst Presenting Brand Therapy Perceptions Goals Admired Brands Brand Narrative Brand Legacy Brand Story Vision, Mission, Promise Primary Messaging Brand Therapy
More informationPartner with the Global Leader in Drug Delivery Systems
3M DRUG DELIVERY SYSTEMS Partner with the Global Leader in Drug Delivery Systems Loughborough, United Kingdom Manufacturing Facility Experts at Commercializing Innovation 3M: Transforming New Ideas into
More informationinnovative products. faster to market. reliably supplied.
innovative products. faster to market. reliably supplied. consumer health E DEVELOPMENT DELIVERY SUPPLY We create unique, tailored consumer health solutions to help your brand grow. With more differentiated
More informationTaking Health & Nutrition to the NEXT Level
Taking Health & Nutrition to the NEXT Level 1. Who We are 2. Softigel by Procaps 3. Strategically Located sites Take 10 minutes to get to know us better 4. Our Quality Certifications 5. Product Development
More informationBecause you care about CONSUMERS HEALTH
Because you care about CONSUMERS HEALTH PROFILE PUBLIC HEALTH Today, as new food and water-related risks continue to emerge, and at a time when the relationships between infectious diseases, cancer and
More informationEPIDEMIOLOGY. Accurate, in-depth information for understanding and assessing targeted markets
EPIDEMIOLOGY Accurate, in-depth information for understanding and assessing targeted markets WHY ACCURATE MARKET FORECASTS Start with accurate understanding Epidemiology is the study of disease patterns
More informationHUMAN FACTORS ENGINEERING OF SELF-INJECTION DEVICES
HUMAN FACTORS ENGINEERING OF SELF-INJECTION DEVICES In this overview, Tobias Nemeth, Business Development Manager, Ypsomed Delivery Systems, provides a useful insight into human factors engineering. The
More informationPartnering in Oncology Sharing a Vision to Help Prolong and Improve Patients Lives. Oncology Therapeutic Area Janssen Research & Development, LLC
Partnering in Oncology Sharing a Vision to Help Prolong and Improve Patients Lives Oncology Therapeutic Area Janssen Research & Development, LLC The patients are waiting. Dr. Paul Janssen To Our Potential
More informationLeader in custom manufacturing. for the pharmaceutical and nutraceutical industries.
Leader in custom manufacturing for the pharmaceutical and nutraceutical industries. Since its inception in April 1994, Viva Pharmaceutical Inc. has built a reputation as a leading manufacturer committed
More informationChronic Care North America update Coloplast Capital Markets Day 2018 Manu Varma, Senior Vice President, Chronic Care Management, NA
Chronic Care North America update Coloplast Capital Markets Day 2018 Manu Varma, Senior Vice President, Chronic Care Management, NA US Chronic Care has outperformed the market by a factor 2-3x and continues
More informationDEVELOPMENT OF PLATFORM INJECTION DEVICES ADDRESSING HUMAN FACTORS AT AN EARLY STAGE FOR DIFFERENT USER GROUPS
DEVELOPMENT OF PLATFORM INJECTION DEVICES ADDRESSING HUMAN FACTORS AT AN EARLY STAGE FOR DIFFERENT USER GROUPS In this article Orfeo Niedermann, Business Development Director, and Jakob Lange, PhD, Account
More informationNATIVA GROUP. Inspired by Innovation and Technology
NATIVA GROUP Inspired by Innovation and Technology INNOVATION & TECHNOLOGY IS OUR PASSION Nativa is a leading group of pharmaceutical companies in Russia. It develops and produces worldclass complex medicines
More informationThe more question you ask the more different answers you will get
The more question you ask the more different answers you will get Experience and lessons learned in China Ulrike Bauer Cicor Innovation Insights Symposium Kloten, September 27, 2016 Agenda Introduction
More informationTHE CORPORATE REPUTATION OF PHARMA 2015 THE PERSPECTIVE OF 139 PATIENT GROUPS with an interest in DIABETES
THE CORPORATE REPUTATION OF PHARMA 2015 THE PERSPECTIVE OF 139 PATIENT GROUPS with an interest in DIABETES PUBLISHED AUGUST 2016 There is growing distrust of pharma in light of several recent and dramatic
More informationNAVIFY Tumor Board NAVIFY
NAVIFY Tumor Board Make the most informed personalized treatment decisions possible by leveraging innovative technologies and the latest scientific and clinical data WHAT S INSIDE Key Takeaways NAVIFY
More informationN a s d a q : I N S Y
N a s d a q : I N S Y 0 Safe Harbor Statement This presentation contains both historical information and forward-looking statements. Forward-looking statements are based on management's current expectations
More informationHARD TWO-PIECE HPMC CAPSULES FOR PHARMACEUTICAL APPLICATIONS IN INHALATION
HARD TWO-PIECE HPMC CAPSULES FOR PHARMACEUTICAL APPLICATIONS IN INHALATION 2 3 QUALICAPS HISTORY Over one hundred years of experience in the manufacturing and filling of hard two-piece capsules Qualicaps
More informationFor personal use only
AusCann Makes Major Progress Towards Production of Cannabinoid Medicines During FY18 Highlights Undertook comprehensive pharmaceutical development project to create an optimal dosage form cannabinoid medicine
More informationInnovator in Chelated Mineral Nutrition
Leader The World & Innovator in Chelated Mineral Nutrition 2011 Albion Human Nutrition. All rights reserved. Albion Manufacturing Technologies, Ogden Utah Albion Central Warehouse, Ogden Utah Albion Corporate
More informationBioequivalence Requirements: USA and EU
Bioequivalence Requirements: USA and EU Dr. Nicholas Cappuccino Chair, IGPA Science Committee Global Head of Quality, Dr. Reddy s Laboratories Ltd. 15 th Annual IGPA Conference Kyoto, Japan December 6,
More informationBayer and Loxo Oncology to develop and commercialize two novel oncology therapies selectively targeting genetic drivers of cancer
Investor News Not intended for U.S. and UK Media Bayer AG Investor Relations 51368 Leverkusen Germany www.investor.bayer.com Bayer and Loxo Oncology to develop and commercialize two novel oncology therapies
More informationDuPont Nutrition & Health Craig Binetti, President
Craig Binetti, President Regulation G The attached charts include company information that does not conform to generally accepted accounting principles (GAAP). Management believes that an analysis of this
More informationExcellence in Trial Management
Excellence in Trial Management COMPANY OVERVIEW Privately held company Founded in 2007 Contract Research Organization HQ in Montréal, Canada Specialized in Clinical Development & Trial Management Client
More informationPolymun Scientific Immunbiologische Forschung GmbH. Liposome Technology
Polymun Scientific Immunbiologische Forschung GmbH Liposome Technology Services Formulation Development Analytical Method Development Process Development GMP Production Filling Clinical & Regulatory Support
More information040716_ANDI_VENTIS WEBSITE(new) Printout 1. HOME PAGE. Welcome to our world of Dry Powder Inhalers!
1. HOME PAGE Welcome to our world of Dry Powder Inhalers! Andi-Ventis Ltd, established in 2001 is a joint venture between Medochemie Ltd, Cyprus and Miat SpA Italy, founded to carry out the pharmaceutical
More informationTRANSDERMAL INNOVATION
TRANSDERMAL INNOVATION 2 TRANSDERMAL MILESTONES Success starts with a vision. An idea that will make a difference. A goal you never lose sight of. At LTS, this goal has always been clear: To offer alternatives
More informationMichel BAIJOT Vice President, WW Business Development & Strategic Alliances
Technology Transfer and Vaccines: The GSK Experience WHO Workshop on Technology Transfer for Local Manufacturing Capacity of Vaccines Geneva, November 30th, 2010 Michel BAIJOT Vice President, WW Business
More informationRegulatory Support for Tobacco Products. Feeling daunted by the regulatory process for tobacco products? Don t worry Battelle can help.
Regulatory Support for Tobacco Products Feeling daunted by the regulatory process for tobacco products? Don t worry Battelle can help. PREMARKET TOBACCO (PMTA) HUMAN FACTORS STUDIES SUBSTANTIAL EQUIVALENCE
More informationSubmitted to the House Energy and Commerce Committee. Federal Efforts to Combat the Opioid Crisis
STATEMENT FOR THE RECORD Submitted to the House Energy and Commerce Committee Federal Efforts to Combat the Opioid Crisis October 25, 2017 America s Health Insurance Plans 601 Pennsylvania Avenue, NW Suite
More informationOffice of ENERGY Science
Date: April 29, 2016 U.S. DEPARTMENT OF Office of ENERGY Science SLAC Site Office SLAG National Accelerator Laboratory 2575 Sand Hill Road, MS-.8A Menlo Park, GA 94025 To: Chi Chang Kao, SLAC Laboratory
More informationSound Off DR. GOOGLE S ROLE IN PRE-DIAGNOSIS THROUGH TREATMENT. Ipsos SMX. June 2014
Sound Off DR. GOOGLE S ROLE IN PRE-DIAGNOSIS THROUGH TREATMENT June 2014 Ipsos SMX : Sound bits (of advice) and bites (of research) from Ipsos SMX Ipsos social media research division, dedicated to providing
More informationQuality Management System Certification. Understanding Quality Management System (QMS) certification
Quality Management System Certification Understanding Quality Management System (QMS) certification The medical device manufacturing sector is one of the most regulated sectors in which significant quality
More informationAlready improving the health and fitness of. more than 122,000 people in nine countries.
Already improving the health and fitness of more than 122,000 people in nine countries. Pixformance is reinventing the physical training experience with the first technology solution to motivate and actively
More informationBUILDING BUSINESS THROUGH SYNERGY
BUILDING BUSINESS THROUGH SYNERGY BioAktive Specialty Products is a supplier of ingredients for use in personal care and nutrition. With a presence in both Europe and Asia we work with our distribution
More informationCompany presentation Frankfurt, Enzymes and carbohydrate ingredients for a healthy nutrition
Company presentation Frankfurt, 9.11.2016 Enzymes and carbohydrate ingredients for a healthy nutrition Lars Wiemann BD-Manager evoxx technologies GmbH Agenda Evoxx technologies GmbH - History, overview,
More informationGraft Delivery Devices
Graft Delivery Devices About Graft Delivery Devices Nordson MEDICAL Nordson MEDICAL is your partner in the global life sciences market providing innovative components, devices and custom OEM solutions
More informationSupport for adults with autism
Support for adults with autism A world where people with autism are universally understood and accepted as equal citizens We are the leading charity in the West Midlands for people with autism. We use
More informationMass Spectrometry Made Simple for Clinical Diagnostic Labs
Mass Spectrometry Made Simple for Clinical Diagnostic Labs The SCIEX Topaz System with FDA-Cleared Topaz Vitamin D 200M Assay Kit Mass Spectrometry Made Simple SCIEX Topaz System for Clinical Diagnostics
More informationPhotocure ASA Executing the Strategy
Photocure ASA Executing the Strategy NOVEMBER 2012 ERIK DAHL, CFO KATHLEEN DEARDORFF, COO Disclaimer The information included in this Presentation contains certain forward-looking statements that address
More informationRising to the Challenge of Satisfying Unmet Medical Needs. Back-of-the-eye. Main Back-of-the-Eye Diseases. Uveitis. Behcet s disease.
Feature Rising to the Challenge of Satisfying Unmet Medical Needs Eyeing Further Specialization Back-of-the-eye Diseases Main Back-of-the-Eye Diseases Age-related macular degeneration Uveitis Behcet s
More informationDifferentiate your brand. with the unique look and performance of capsugel s press-fit and xpress-fit gelcaps. capsugel.com
Differentiate your brand with the unique look and performance of capsugel s press-fit and xpress-fit gelcaps capsugel.com Imagine the possibilities Breathe new life into existing product lines. Build your
More informationONCOLOGY: WHEN EXPERTISE, EXPERIENCE AND DATA MATTER. KANTAR HEALTH ONCOLOGY SOLUTIONS: FOCUSED I DEDICATED I HERITAGE
CATALYSTS DRIVING SUCCESSFUL DECISIONS IN LIFE SCIENCES ONCOLOGY: WHEN EXPERTISE, EXPERIENCE AND DATA MATTER. KANTAR HEALTH ONCOLOGY SOLUTIONS: FOCUSED I DEDICATED I HERITAGE AT KANTAR HEALTH, ONCOLOGY
More informationDIABETES - FACT SHEET
DIABETES - FACT SHEET What is diabetes? Diabetes mellitus, often shortened to diabetes, is a chronic condition that affects the body's ability to control blood sugar level and use energy from food. In
More informationProduct Information for Labs. etkon ident Perfectly versatile. Performance you can rely on.
Product Information for Labs etkon ident Perfectly versatile. Performance you can rely on. BENEFIT FROM THE BEST OF BOTH WORLDS Versatility Simplicity Industry-leading manu facturing standards Variety
More informationA study to test whether BI improves mental abilities in people with mild Alzheimer s disease and difficulties with mental functioning
A study to test whether improves mental abilities in people with mild Alzheimer s disease and difficulties with mental functioning This is a summary of a clinical study in Alzheimer s disease. It is written
More informationNews Release. December 9, Not intended for UK-based media
Your Contacts News Release Merck Media: Gangolf Schrimpf +49 6151 72-9591 Investor Relations: +49 6151 72-3321 Pfizer Media: Sally Beatty +1 212 733 6566 Investor Relations: Ryan Crowe +1 212 733 8160
More informationCOIL PROCESSING SOLUTIONS
COIL PROCESSING SOLUTIONS CELEBRATING 110 YEARS About Us The RDI Group, the parent company of Chicago Slitter, RDI Laser Blanking Systems, and RDI Punching & Bending Systems, celebrates over 110 years
More informationCOMMENTS. Submitted by The International Pharmaceutical Aerosol Consortium
COMMENTS on a draft Guidance for Industry Nasal Spray and Inhalation Solution, Suspension, and Spray Drug Products Chemistry, Manufacturing, and Controls Documentation (Docket No. 99D-1454) Submitted by
More informationBioanalytical Overview
LC-ICP-MS LC-MS/MS GYROS HYBRIDIZATION-ELISA ELISA BIOANALYTICAL OVERVIEW ECL ICP-MS Bioanalytical Overview QPS is your Global Link to all your Bioanalytical Sourcing Needs Introduction to QPS Global Bioanalytical
More informationIntroducing BSI. BSI Medical Device Regulatory Update Galway, Ireland. Dr. Michael Weissig EMEA Vice President Healthcare 26 June, 2015
Introducing BSI BSI Medical Device Regulatory Update Galway, Ireland Dr. Michael Weissig EMEA Vice President Healthcare 26 June, 2015 Copyright 2014 BSI. All rights reserved. Global Healthcare Mission
More informationGlobal Strategic Partners Merck and Pfizer Finalize Agreement to Co-Promote XALKORI (crizotinib)
Merck Media: Markus Talanow +49 6151 72 7144 Investor Relations: +49 6151 72 3321 Pfizer Media: Sally Beatty +1 212 733 6566 Investor Relations: Ryan Crowe +1 212 733 8160 News Release April 7, 2015 Not
More informationSavesta Herbals is engaged in manufacturing
Savesta Herbals is engaged in manufacturing standardized herbal extracts that synergistically combine the ancient wisdom of Ayurveda with the modern production and QC methods. Our state-of- the- art production
More informationReady for a CRO That Values Performance Over Promises? CHALLENGE. At Clinipace, it s personal.
Ready for a CRO That Values Performance Over Promises? CHALLENGE At Clinipace, it s personal. Who We Are At Clinipace, It s Personal. We Will PROVE IT. With us, you get the A team. We deliver a level of
More informationGlobal Prefilled Syringes Market: Trends, Opportunities and Forecasts ( )
Global Prefilled Syringes Market: Trends, Opportunities and Forecasts (2016-2021) By Material - Glass and Plastic By Filling Capabilities Single Chamber and Dual/Multiple Chamber By Major Applications
More informationORAL DOSAGE OVERVIEW
ORAL DOSAGE OVERVIEW AN UNWAVERING COMMITMENT TO ENABLING LIFE-SAVING PHARMACEUTICALS The safety of your patients is your number one priority. That s why the quality and stability of your formulations
More informationPSYCHIATRY. THE POWER OFx. Experts. Experience. Execution. A Deeper Dive into Psychiatry. Scientifically-Driven Clinical Development
THE POWER OFx Experts. Experience. Execution. A Deeper Dive into Psychiatry Incidences of mental disorders such as depression, bipolar, anxiety disorders, and schizophrenia continue to grow around the
More informationThe Dual Hormonal Artificial Pancreas in Diabetes Management. Medical Innovation Day Challenge
The Dual Hormonal Artificial Pancreas in Diabetes Management Medical Innovation Day Challenge 1 Background for the challenge A paradigm shift in treating diabetes Zealand Pharma is a Danish biotech company
More informationJABRA UNVEILS THE KEY TO ITS INDUSTRY LEADERSHIP
JABRA UNVEILS THE KEY TO ITS INDUSTRY LEADERSHIP A cooperative culture and knowledge sharing with sister companies in the sound and hearing Group - GN Store Nord, is key to the industrial leadership and,
More informationOpportunities and Challenges in the Development of Companion Diagnostics
Opportunities and Challenges in the Development of Companion Diagnostics E. Patrick Groody, Ph.D. Divisional Vice President Research and Development Abbott Molecular Agenda Value of Personalized Medicine
More informationeclinical Solutions Market Share, Size, Analysis, Growth, Trends and Forecasts to 2024 Hexa Research
eclinical Solutions Market Share, Size, Analysis, Growth, Trends and Forecasts to 2024 Hexa Research " Projected to grow at a CAGR of around 12%, eclinical solutions market is expected to witness significant
More informationCommitted to Environment, Health, & Safety
Committed to Environment, Health, & Safety Environment, Health, and Safety Management System and Policy of W. R. Grace & Co. November 8, 2018 The Grace Environment, Health, and Safety Management System,
More informationA GLOBAL LEADER IN PERSONALIZED NUTRITION
A GLOBAL LEADER IN PERSONALIZED NUTRITION Forward Looking Statements Management will make forward-looking statements during this presentation. Actual results could differ from those projected in such forward-looking
More informationINTERIM MANAGEMENT STATEMENT Q3 2017
INTERIM MANAGEMENT STATEMENT Q3 2017 Significant progress across all clinical programs New pre-clinical immunooncology data to be presented during R&D Day in New York Research & Development highlights:
More informationinnovative products. faster to market. reliably supplied.
innovative products. faster to market. reliably supplied. consumer health unique consumer health solutions for otc, supplements & beauty DEVELOPMENT DELIVERY SUPPLY As a global leader in the development
More informationradiation monitoring programs Tailored to your needs
radiation monitoring programs Tailored to your needs Dosimetry Services Division OVERVIEW Mirion Technologies is comprised of five divisions delivering products, services, and solutions in the world of
More informationLOGIQ E9 with XDclear
GE Healthcare LOGIQ E9 with XDclear Make every day extraordinary healthymagination GE imagination at work LOGIQ E9 with XDclear Today, LOGIQ* E9 with XDclear gives you a renewed freedom to use ultrasound
More informationPRA International Early Development Services Bioanalytical Laboratory
PRA International Early Development Services Bioanalytical Laboratory Bioanalytical Laboratories: Retain profitability in a competitive market A View from a Major CRO Houten October 8, 2009 Peter Ketelaar
More informationLakshy Management Consultant Pvt. Ltd.
What is ISO 13485:2003? You can t buy trust. BUILD IT through ISO 13485. Demonstrate your ability to supply medical devices through Quality Management System for Medical Devices - ISO 13485 ISO 13485 is
More informationFor personal use only. Investor Briefing. Bayswater, 1 st December 2016
Investor Briefing Bayswater, 1 st December 2016 Introduction Samantha Cheetham Chief Executive Officer To be an innovative leader in the dental industry, developing our people and partnering with dentists
More informationBoehringer Ingelheim Pharmaceuticals, Inc. & Univision. Making Diabetic Hispanics Healthier
Boehringer Ingelheim Pharmaceuticals, Inc. & Univision Making Diabetic Hispanics Healthier Agenda BIPI and the Hispanic segment Organizing and Executing to Win The Proof is in the Results Making Hispanics
More informationBEWITAL agri Your specialist in milk & fat Production of healthy, nutritional animal feed stuffs.
BEWITAL agri Your specialist in milk & fat Production of healthy, nutritional animal feed stuffs. EXPERTS DEPENDABILITY Creativity Quality Partnership SUSTAINABLE OPERATIONS SECURITY Responsibility trust
More informationThe Company. Beyond Pioneering
The Company Beyond Pioneering Standardisation Bedrocan is the world s most experienced producer of legal medicinal cannabis. We are currently the only company producing medicinal cannabis flos to good
More informationFAMILY & CHILDREN S SERVICES STRATEGIC PLAN
2014-2019 FAMILY & CHILDREN S SERVICES STRATEGIC PLAN WHO WE ARE Family & Children s Services is a leading provider of behavioral health care and family services for people of all ages in Tulsa and surrounding
More informationKarel Stoschek Director Infant Nutrition. Infant Nutrition
Karel Stoschek Director Infant Nutrition Infant Nutrition Infant Nutrition January to September 70 60 50 40 30 20 10 0 66 52 55 48 32 2010 2011 2012 2013 2014 140 120 100 80 60 40 20 0 123 104 82 59 16
More informationCommitted to Environment, Health and Safety
Committed to Environment, Health and Safety Environment, Health and Safety Management System and Policy of GCP Applied Technologies Inc. SEPTEMBER 1, 2017 The GCP Environment, Health, and Safety Management
More informationAmerican College of Healthcare Executives 2018 Chapter Development Report Division of Regional Services March 2018
American College of Healthcare Executives 2018 Chapter Development Report Division of Regional Services March 2018 Since the establishment of chapters in 2004 the Chapter Development Report has tracked
More informationMedicinal Marihuana Science, Redefined
Medicinal Marihuana Science, Redefined From Concept to Commercialization.... www.avantirx.com WELL BEYOND COMPLIANCE Medicinal Marihuana Science, Redefined... ARA Avanti Rx Analytics Inc. is a Health Canada
More informationEvolutionary Outsourcing Model: Delivering Solutions through Partnership. Tammy Harter and Tony Parry Clinical Bioanalysis Alliance (CBioA)
Evolutionary Outsourcing Model: Delivering Solutions through Partnership Tammy Harter and Tony Parry Clinical Bioanalysis Alliance (CBioA) Introduction Pre Alliance Years History Drivers for change The
More informationValue growth in Human Nutrition & Health
Value growth in Human Nutrition & Health Rick Greubel President Human Nutrition & Health US Field Trip September 4, 2014 Safe harbor statement This presentation may contain forward-looking statements with
More information37 th ANNUAL JP MORGAN HEALTHCARE CONFERENCE
37 th ANNUAL JP MORGAN HEALTHCARE CONFERENCE January 2019 Safe Harbor Statement This presentation contains forward-looking statements within the meaning of Section 27A of the Securities Act of 1933, as
More informationph Meters Market Share, Size, Analysis, Growth, Trends and Forecasts to 2024 Hexa Research
ph Meters Market Share, Size, Analysis, Growth, Trends and Forecasts to 2024 Hexa Research " The ph meters market is expected to grow at a CAGR of 3% over the forecast period from 2016 to 2024." 31 October
More informationASCO Abstract # Avelumab: 4009, TPS4134, TPS4135, 9036, TPS9105, 3055, TPS3106, 8503, 4514, 4516, 5533, TPS5600, TPS4580, 9508; tepotinib: 4072
Your Contact Gangolf Schrimpf +49 6151 72-9591 ASCO Abstract Avelumab: 4009, TPS4134, TPS4135, 9036, TPS9105, 3055, TPS3106, 8503, 4514, 4516, 5533, TPS5600, TPS4580, 9508; tepotinib: 4072 May 18, 2016
More informationGlobal Stevia Extracts Market Analysis By Type (Dried, Leaves, Powder, Liquid), Application, Region, Country: Opportunities and Forecast ( )
Global Stevia Extracts Market Analysis By Type (Dried, Leaves, Powder, Liquid), Application, Region, Country: Opportunities and Forecast (2017-2022) Analysis By Type - Fresh/Dried leaves, Stevia powder,
More informationPatrick J. Sullivan, President & CEO March 7, 2016 Raymond James 37 th Annual Institutional Conference
Patrick J. Sullivan, President & CEO March 7, 2016 Raymond James 37 th Annual Institutional Conference Forward Looking Statement This presentation may contain forward-looking statements concerning Insulet's
More informationADVANCIA : A TRUE PLATFORM & INNOVATIVE SYSTEM OFFERING EFFICIENT NASAL DOSE DELIVERY
ADVANCIA : A TRUE PLATFORM & INNOVATIVE SYSTEM OFFERING EFFICIENT NASAL DOSE DELIVERY Millions of people suffering from allergic rhinitis use nasal sprays manufactured by Nemera every day. In this article,
More informationEXPANDING WHAT S POSSIBLE WITH THE RIGHT PARTNER. Life-saving pharmaceuticals start with high-quality ingredients
EXPANDING WHAT S POSSIBLE WITH THE RIGHT PARTNER Life-saving pharmaceuticals start with high-quality ingredients CONFIDENCE STRAIGHT FROM THE SOURCE From oral dosage excipients (Rx, Gx, nutraceuticals
More informationLOGIQ E9 with XDclear
GE Healthcare LOGIQ E9 with XDclear Make every day extraordinary healthymagination GE imagination at work LOGIQ E9 with XDclear Today, LOGIQ* E9 with XDclear gives you a renewed freedom to use ultrasound
More informationMerrill Lynch Pharmaceutical, Biotechnology & Medical Device Conference New York, February 4, 2004
Merrill Lynch Pharmaceutical, Biotechnology & Medical Device Conference New York, February 4, 2004 Disclaimer 2 This presentation contains forward-looking statements, i.e., current estimates or expectations
More informationWELCOME. To learn more or place an order, please call
PRODUCT CATALOG WELCOME OUR VALUES American Regent is committed to providing you with a growing and diversified portfolio of specialty injectable products to help meet the needs of today s ever-changing
More information